A novel CAR-T cell therapy is being studied for its potential to treat various types of cancer, including blood and breast cancers. The therapy has received a breakthrough designation and is being explored in clinical trials, with some studies indicating it is safe and effective in treating certain types of lymphoma. Research on the therapy's application to solid tumors and other cancers, such as acute myeloid leukemia, is also underway.